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William van Treuren21, Daniel Waweru12 and Steve J Kemp22Abstract
To augment capacity-building for microbiome and probiotic research in Africa, a workshop was held in Nairobi,
Kenya, at which researchers discussed human, animal, insect, and agricultural microbiome and probiotics/prebiotics
topics. Five recommendations were made to promote future basic and translational research that benefits Africans.Introduction
The rapid expansion of microbiome [1-5] and probiotic
[6-9] research over the past 10 years and the many spin-
offs providing novel insights into human and animal dis-
eases, as well as products designed to alleviate them, have
been primarily driven by sizeable funding from developed
countries, especially Canada, USA and Europe.
The first study conducted in Africa was based upon 16S
rRNA gene sequencing, utilizing Illumina (San Diego, CA),
and revealed a microbiome of relatively high diversity in
the vagina of Tanzanian women infected with HIV [10].
This was followed by an intriguing study of children from
a rural village in Burkina Faso, whose high-fiber diet is
similar to that eaten in early human settlements at the time
of the birth of agriculture [11]; compared to European chil-
dren, the latter study found a significant enrichment in
Bacteroidetes and depletion in Firmicutes (P < 0.001), with
a unique abundance of bacteria from the genus Prevotella
and Xylanibacter, enriched in bacterial genes for cellulose
and xylan hydrolysis. Such continental-comparative studies
can be revealing in terms of understanding how the envir-
onment and diet influence health, disease and weight gain,* Correspondence: gregor@uwo.ca
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Immunology, and Surgery, University of Western Ontario, 268 Grosvenor
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unless otherwise stated.especially since it is known that modern diet and lifestyle
can cause a dramatic change to the human gut microbiome
[12]. Ironically, urban regions of Africa are transitioning to-
wards a lifestyle and fast-food diet typical of ‘Westernized’
societies, potentially bringing with it an increased risk of
metabolic diseases, such as diabetes. It will be interesting
to see if the gut microbiome, shown to have a higher
abundance of Bifidobacterium and a different Bacteroides-
Prevotella ratio at 6 months of age in resource disadvan-
taged Malawi compared to higher-income Finland, converts
to one similar to Finland or the US [13]. Only minor differ-
ences were observed between the microbiota of subjects in
Finland and Germany, emphasizing the African deviation
[14]. This could have major implications as the microbiota
affect energy extraction from food, possibly resulting in
obesity. On the other hand, a particular nutritious diet
might enhance beneficial microbiota to help lower the risk
of diarrheal diseases and improve child health.
This improved knowledge of the microbial composition
provides a new focus to examine the consequences of
intervention studies. The importance of this is illustrated
by a Swiss-led study in Ivory Coast which showed that not
only was iron fortification through biscuits ineffective for
iron-deficiency anemia, but it worsened the unfavorable
ratio of fecal Enterobacteriaceae to Bifidobacterium
and Lactobacillus [15]. Other microbiome and com-
parative microbial genome studies have contributed tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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isms in the environment [16] and how these might
have been impacted by various niches [17,18]. Of par-
ticular interest is the gut microbiome of the malaria
mosquito [19], perhaps as a first step in manipulating
it to lower infectivity of the parasite. Fermented foods
have a long history of use in Africa, and in recent
years efforts have been made to identify the microbial
strains and propagate them as probiotics to confer
additional health benefits [20-23]. Some studies have
shown the benefits of probiotics in the gut and vagina
of HIV-infected patients in Africa [24,25], while in one
report a combination of probiotic and prebiotic failed to
resolve acute severe malnutrition in children from Malawi
[26]. Knowledge gaps remain to be investigated with
respect to African subjects. For example, studies which
assess the male urinary tract microbiota have been
conducted in Europe [27], but in Africa studies have
examined the effect of circumcision on the corona sulcus
microbiota. As the interchange of male and female micro-
biota may have important consequences for health, coord-
inating such studies amongst different populations would
be worthwhile.
In agreement with the sentiments brought forth by
van Helden and colleagues [28] that humans, animals
and the environment are inextricably linked and equal
attention is needed to ensure optimal health for all, we
convened a workshop in Nairobi, Kenya, at the Inter-
national Livestock Research Institute (ILRA). The overall
goal was to develop evidence-based concepts aimed at
improving the health and wealth of people in African
countries, with emphasis on mother and child, and local
production and increased accessibility to nutritious and
affordable products, integrated with effective education
and training at community and academic levels. Three
specific objectives of the workshop were: (1) discuss
human, animal, insect, and agricultural microbiome as
well as probiotics/prebiotics research in, or planned for,
Africa; (2) engage African scientists and clinicians as well
as help facilitate training focused on basic and transla-
tional research in the areas of microbiome investigations
that promote sustainable, locally derived disease inter-
ventions; and (3) create new research initiatives and make
recommendations to enhance African infrastructure, ex-
pertise and impact on these globally important areas.
The outcomes and conclusions of the meeting are
presented here.
A cross section of researchers from across the world,
with a track record in studying the microbiome and/or
probiotics in Africa were invited. The meeting was
limited to 40 participants for logistical reasons and to
encourage discussion groups to form and come up with
tangible concepts. With no funding to support travel of
delegates, the reliance was upon goodwill and interest inthe topic. Over 70 invitations were made to researchers
based upon their publications in these areas, of which 40
accepted but eight cancelled too late for substitution,
leaving a total of 32 participants from 10 countries. On
day one, participants identified their interests and where
they would like progress to be made. Topics for discus-
sion were then agreed upon and day two was spent in
groups to identify ways to move the topic forward.
There was collective agreement that practical transla-
tional efforts should be prioritized that embrace local in-
volvement and focus on sustainable outcomes. Cognizant
of the realities of funding and the need to develop more
African expertise and infrastructure, there was a com-
mitment from all parties to collaborate and make the
proposed projects actually happen. Figure 1 provides a
summary of the essential components which the partici-
pants felt were needed for success, with education, train-
ing and research being absolutely essential. The following
is a summary of the ideas, projects and recommendations
from these discussions. We welcome interest and contri-
butions by members of the larger scientific community
who read this article.
The extended microbiome of African indigenous cattle
Cattle represent an integral part of society in many
African countries as a source of meat and milk. Diseases
of cattle have major implications for food security as
well as community livelihoods and the economy. In
addition, exposure of cattle to toxins, such as aflatoxins
in maize or heavy metals in the soil, then become prob-
lematic for the consumer of their milk and meat, includ-
ing offals. The cattle population is diversified with many
breeds, but one important East African breed is the
Boran which is both hardy and productive. Hypothesiz-
ing that the microbiome has an important role to play in
productivity and health of cattle, five objectives were
deemed important to better understand the microbiome
composition.
(i) Identify the normal microbiome (bacteria, archaea
and fungi) of Boran cattle, their surface parasites
as well as their feed and environment in three
eco-climatic zones within Kenya. This would
provide insight into seasonal effects, grazing
conditions and help identify microbes associated with
health. All sequencing will be performed at ILRI and
added to the metadata of the Earth Microbiome
Project (http://www.earthmicrobiome.org/). This
will also build capacity by training graduate
students at various East and Central African
universities.
(ii) Characterize the functional capabilities of microbial
populations in the planktonic and mucosal surface
of the rumen of Boran cattle. This will determine
Handling toxinsFermented food, probioticsand health enhancement
Human microbiome and
prevention of diseases 
5. DISTRIBUTION MARKETING
COMMUNICATION
7. POLICIES, ETHICS AND 
GUIDELINES CHECK
1. RESEARCH
2. EVIDENCE BASED 
CONCEPTS
6. CONSUMER
Evaluation of consumer feedback 
and health effects of food 
interventions
3. TRAINING AND EDUCATION
4. LOCAL PRODUCTION
Figure 1 Illustration of the model which we believe is critical for the successful expansion of microbiome and probiotic research and
product development, as well as the engagement of all parties whose input is needed to the process. Three examples of drivers for the
research are given: fermented foods, the problems with inadvertent ingestion and handling of environmental toxins, and the need for remedies
to treat and prevent disease.
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by-products and impact on host immunity.
(iii) Determine the difference in microbial function
when feed is contaminated with aflatoxins. The
Food and Agriculture Organization estimates that
25% of the world’s food crops are affected by
mycotoxins, with losses to livestock and poultry
producers from aflatoxin-contaminated feeds
resulting in death and effects on immune system
suppression, reduced growth rates, and losses in
feed efficiency. Aflatoxins are secondary metabolites
produced by species of Aspergillus, specifically
Aspergillus flavus and parasiticus fungi, which
grow well on maize, peanuts and other foods
under relative humidity/moisture and poor storage
conditions. These compounds are highly toxic,
mutagenic, teratogenic and carcinogenic, causing
human hepatic and extrahepatic cancers. Regions of
Kenya are known to be at high risk of aflatoxin
contamination and this could adversely affect yield
and increase risk for humans who consume the
meat and milk. Indeed, one study of 830 animal
feeds and 613 milk samples from four Kenyan
urban centers showed 86% of the former werepositive for aflatoxin B1 and 67% of these exceeded
the Food and Agriculture Organization/World
Health Organization level of 5 μg per kg maize
meal [29]. Seventy two percent of the milk from
dairy farmers, 84% (71/85) from large- and
medium-scale farmers and 99% (88/89) of the
pasteurized marketed milk were positive for
aflatoxin M1. A major outbreak of aflatoxin
poisoning in 2004 resulted in 317 human cases and
125 deaths as well as countless dead wildlife. The
toxin can also stimulate commensal organisms to
express other toxic compounds afflicting the cows
[30]. The potential increase in kwashiorkor due to
mycotoxin exposure is particularly relevant given
the importance of the microbiome in this condition
[31]. The proposed study in Boran cattle will
therefore have implications for livestock productivity
and human health. Of importance would be to try
to quantitate aflatoxin levels, as chronic exposure
is problematic over time.
(iv) Determine differences in microbial rumen
composition and function in cattle associated
with the presence and transmission of zoonotic
pathogens. This study will identify any microbial
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beneficial profiles exist, these could form the basis
for whole microbial transplantation, perhaps soon
after birth. Coprophagy is commonplace in some
animals, either to help develop a digestive
microbiota or to act as a source of vitamins that
are produced by the gut bacteria and then are part
of the stool composition [32].
(v) A final component of these studies on Boran cattle
would be to identify viral sequences in the
transcriptome, and bank environmental DNA,
RNA and rumen samples for later analysis.
The proposed studies are achievable within 2 years and
would form a sound basis for many future approaches to
management of livestock. These could include the relation
to the effect on health and productivity by the environ-
ment, feed quality and composition, toxins, antimicrobials,
heavy metals and pesticides. In addition, further insights
on the reduction of methane production due to rumen
bacteria could be obtained.
The African Microbiome Project
The outstanding advances made possible through the
Human Microbiome Project [33] have transformed our
perception of health and disease. The current data were
largely derived from North American/European subjects,
and extrapolation to African subjects may be pertinent.
As very few studies have been performed on microbialMorocco
Guinea Bisseau
South Africa
Ghana
Central African 
Republic
Gambia
Figure 2 Countries that can be targeted to perform a clinical trial on
upon existing infrastructure and collaborations, as well as extent of the sepdiversity in African humans, soil, insects, birds, fish and
animals, this precludes determination of associations
with health and disease. It would be presumptive to sug-
gest skewing of microbial composition linked to negative
impact on health in developed countries, are applicable in
another setting. Therefore, the studies are worth replicat-
ing in Africa. Two important projects are currently under-
way: The American Gut Project (http://www.microbio.
me/americangut/FAQ.psp) is currently surveying the
diversity of 10,000 subjects (all ages, both sexes, no exclu-
sions) in North America, and The Asian Microbiome
Project is comparing diversity of subjects across 11 sites
(all ages, both sexes, including a sub-focus on mothers and
healthy children). It is unclear how readily concepts de-
rived from these data sets could be extrapolated to African
subjects. We hereby propose ‘The African Microbiome
Project’, with the objective of determining taxonomic and
functional (metagenomic) diversity of the bacteria present
in the feces of 10,000 African subjects.
To follow the design of the American and the Asian
studies, the ideal would be to collect the stools across
around 10 African sites (approximately 1,000 subjects
per site; Figure 2). These would be processed and then
shipped to ILRI in Nairobi or an equivalent site in Africa
for shot-gun sequencing to determine taxonomic compos-
ition and metagenomic functional pathway representation.
Extensive metadata would be collected on participating
subjects using a universal form to allow association with
clinically important phenotypes.Egypt
Kenya
Rwanda
Malawi
Zambia
Madagascar
probiotics to prevent sepsis in children. The selection is based
sis problem.
Table 1 A list of resources
MIMARKS provides standards on how to collect and record data
Tutorial http://www.microbio.me/qiime/docs/
tutorials/tutorial.html
Examples available at: http://www.
microbio.me/qiime/
Register (free, 2-minute process)
then retrieve hundreds of examples.
Tools ‘Omics’ data requires bioinformatic
pipelines: QIIME, Mothur, LEfSe,
MetaPhlAn, USEARCH, UPARSE,
PandaSeq, and others. They are
relatively complicated and
non-intuitive, but the following sites
are particularly helpful:
QIIME forum: https://groups.google.
com/forum/#!forum/qiime-forum
Mothur: http://www.mothur.org/
wiki/Main_Page
SeqAnswers: http://seqanswers.com/
forums/index.php
StackExchange: http://biology.
stackexchange.com/
Local clusters As ‘Omics’ tools require
computational power, it may be
feasible to have a local cluster
through AWS Educational Grants:
http://aws.amazon.com/education/,
or partner with a bioinformatics lab
such as via Project Rosalind: http://
rosalind.info/about/ and Project
Euler: http://projecteuler.net/
Sample collection and processing
protocols, bioinformatics pipelines
and technical information
EMP: http://www.earthmicrobiome.
org/emp-standard-protocols/
HMP: http://www.hmpdacc.org/
QIIME/Mothur workshops online as
above, and distance workshops
such as:
STAMPS: http://hermes.mbl.edu/
education/courses/special_topics/
stamps.html
QIIME tutorials: https://www.qiime.
org/tutorials
Software Carpentry: http://software-
carpentry.org/
NGS overviews: http://informatics
training.hms.harvard.edu/
Open courses Open courses are also available:
Coursera: https://www.coursera.org/,
such as Biostatistics boot camp,
Machine learning, Bioinformatics
methods with an MIT site being
helpful. http://ocw.mit.edu/index.htm
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– For pregnant women: number of children, parity,
whether term or preterm, vaginal or caesarean birth,
and duration of breast-feeding.
– For infants: growth (height, weight), status at birth
and need for any interventions, developmental
screening and cognition, whether breast-fed or
formula or other, and time of weaning.
– For all subjects: race, tribe, diet, foods, blood
pressure, health history, known medications and
vaccines received, HIV status, gastrointestinal
problems, household size and density, exposure
to animals in the home, duration at present
residence, hygiene and access to toilet. Urine
samples will also be acquired to allow future
microbiota assessment and metabolic/functional
correlative analysis [34].
The expected data resulting from such a study would
not only be a tremendous resource of high-quality data
on the African microbiome (taxonomic and functional),
from a broad representation of multiple groups (urban/
rural; different cultures; traditional and ‘Westernized’
food), but provide a rich platform for hypothesis-gene-
rating future studies using well established tools (see
“Metadata and data handling” below. The next step cur-
rently under way is to identify relevant funding sources
and align multi-disciplinary and multi-national teams to
commence project planning in 2014.
Metadata and data handling
The group reached consensus that samples collected
in Africa should be analyzed by African trainees on
site where possible. Thus, discussion centered around
ways for this goal to be achieved. With regard to collect-
ing, storing and sharing metadata, it would be useful to
communicate the importance of collecting standard
metadata for all samples [35]. There are a number of
state-of-the-art and readily accessible resources avail-
able for Africans wishing to collect and use metadata,
and the MIMARKS standard was put forward as the
most widely used and general standard that should be
adopted for future studies. A resource list is provided
in Table 1.
Clinical trial on sepsis
In sub-Saharan Africa, sepsis is the cause of at least 10%
of all maternal deaths and 26% of neonatal deaths [36].
Many factors contribute to these unacceptable high rates
of infection: poor or delayed diagnosis, access to care,
and inadequate therapy. A recent study, so far presented
orally but unpublished except in abstract form [37], of
over 4,000 infants in a resource-disadvantaged setting inIndia reported that daily administration for 1 week of
probiotic Lactobacillus plantarum with 150 mg fructo-
oligosaccharide prebiotic in maltodextrin within 72 hours
of birth reduced death or sepsis by 44%, and occurrence
of pneumonia requiring antibiotics by 36%. The study
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trolled trial [38].
Whilst the full details of the study design and actual
results still have to undergo adequate peer-review, with
questions over the availability of a patent-protected
formula, the workshop participants considered that a
repetition of this study could be very relevant for the
situation in Africa. The probiotic formulation will have
to be carefully considered, taking into account the local
prevailing strains as well as available resources. Besides
Lactobacillus plantarum, another option would be Lacto-
bacillus rhamnosus Yoba, basically an isolate of the GG
strain, but named differently as LGG is off-patent [39],
which is available in African in dried sachets.
The GG strain has been used safely in pregnant
women and infants and has been shown to prevent diar-
rhea [40-42], indicating appropriateness for use in clinical
settings. Additional design issues discussed were focused
to assess not simply clinical outcome but also to begin
assessing the mechanism(s) of action (presumed to be
reduction of neonatal sepsis). To this end we would want
to enroll the pregnant mother and sample her microbiome
close to birth in a clinical trial and sample stool, saliva,
skin, vagina as close as possible after birth. This would
allow us to ask: is maternal microbiome-transfer to infant
affected by probiotic intervention? We would also want to
compare microbiome of the enrolled infants over the first
year (stool, saliva, skin), allowing us to ask “does probiotic
intervention change infant microbiome?”, and collect
blood to test the impact of the probiotic intervention on
innate and adaptive immune development, allowing us to
ask “does probiotic intervention alter immune develop-
ment, and does this correlate with increased protection?”.
We would also want to collect blood, urine and milk to
measure metabolome and aflatoxins of pregnant and
lactating women, allowing us to investigate if the probiotic
intervention alters metabolome and toxin concentration,
and the amount transferred to the infant.
Embracing African fermented foods and plant-based
micronutrients
Despite a long history of a large variety of fermented
foods across Africa [43,44], these are not necessarily be-
ing passed down to the next generation or incorporated
in the food-based dietary guidelines. The perception
conveyed by young urban people is that their generation
does not have time to wait for traditional fermented
foods that take a while to prepare or cost too much, or
are considered inferior because of their taste and quality
(as a result of non-standardized artisanal practices). The
Westernization/urbanization of African society, at least
in cities, was seen as a barrier to embracing most
fermented foods unless they could be made available as
an affordable, easy and tasty option. A means to do thiswas discussed, particularly around three popular Kenyan
foods: Uji, Black nightshade and Murzik. Given the
reported health benefits of fermented foods [45-47], the
view was that consumption of these foods should be
encouraged, especially since they are part of the trad-
itional healthy diet.
The following facets, based upon bottom-of-the-pyra-
mid principles [48], believed to be important for a new
approach to fermented foods were:
 Ability to create Uji or another local food as a
freshly made, fast, tasty, affordable option.
 Standardized starter cultures for consistent
product quality.
 Continuous product development and product
innovation based on locally available crops.
 A single message that fermented foods are
beneficial to health.
 Aggressive and effective marketing, as per
current fast food companies, and including
use of social media.
 Nutritious and safe original local products.
 A formulation that has the potential to improve
maternal-child and youth health.
 Education and training of consumers and
producers based on good scientific evidence.
In order to succeed, youth and new mothers would be
targeted as a means of consumer engagement, and also
as they are at high risk of obesity and diabetes, and they
tend to eat more Westernized fast foods (http://apps.
psychiatry.ufl.edu/Newsletters/Archive/Brownell-Kelly/
FastFoodFACTS_Report_Summary.pdf). While many busi-
ness models could work, the idea of franchising had
appeal, where each city site could develop a novel product,
share these amongst themselves and deliver a consistent
single message that fermented foods are beneficial. The
model is shown in Figure 3. In creating the products,
microbial strain identification, storage, handling and re-
producible processing would be a priority. For sustaina-
bility, cooperation amongst the franchises would allow for
continuous product innovation, especially when linked
with universities (different faculties), the Ministries of
Agriculture and Health, and farmers. In addition, collabo-
rations would be needed to ensure a continuous supply of
raw materials and account for seasonal variations and crop
growth cycles.
The addition of micronutrient rich plants was recom-
mended, and Moringa, already used in community yogurt
kitchen projects in Tanzania [49] and widely available
across Africa, was considered a source of micronutrients,
along with amaranth [50] and managu (Solanum pseudo-
capsicum) [51]. Inclusion of such locally sourced products
will enhance collaborations between food scientists and
LIFESTYLE 
DISEASES
PROBLEM
FRANCHISES
IMPROVING ACCESS
INCOME GENERATION
LOCAL RADIO AND 
SOCIAL MEDIA
SHAPING ASPIRATIONS
FERMENTED FOODS
TAILORING LOCAL SOLUTIONS
Fermented foods as business oppurtunity to combat life style diseases and stimulate economic activities
Figure 3 Illustration of the problems emanating from lifestyle changes in African countries, in particular leading to changes in diet. We
believe that fermented food consumption, once a mainstay in many communities, could be re-introduced to counter poor fast foods, but to do
this large efforts are needed in communicating the benefits, and social business models created that permit innovation and independence, and
provide a collective message to the consumer.
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products. Similarly, local foods have been used for food
supplements in nutrition intervention studies in Malawi
[52,53]. A dairy product has also been developed on the
basis of a traditional dish called mutandabota (made from
baobab fruit pulp and sugar), and is widely consumed in
Southern Africa [23].
The challenges and opportunities related to education
and training of consumers, patients, students and
professionals
In order to improve the general health situation, it is key
to focus on training and education of consumers, stu-
dents and professionals, and national authorities. For
instance, consumer education is often lacking in African
countries, with many people not reaching secondary
school level, and many suffering from poor cognitive
function due to malnutrition. Often, information is
passed from generation to generation, in some cases
leading to detrimental outcomes such as early termin-
ation of breast feeding because the milk lacks ‘water’
and should be substituted by water (which is often con-
taminated by pathogens and causes diarrhea), sugar and
other foods. The use of nutritious probiotic and fermented
foods should be promoted through education of people at
risk for malnutrition. This could involve training courses
and/or lectures in existing school and college curricula, and
educating parents and grandparents through communitymeetings. Potentially, university students could play a role
if material was provided to aid them, and measurement
tools created so they can gauge resultant change. The
approach of the Early Years Collaborative (http://www.
scotland.gov.uk/Topics/People/Young-People/Early-
Years-and-Family/early-years-collaborative/resources) in
Scotland is an example where such locally-based initiatives
are tried, tested and transferred across regions as a means
to alter failing processes. It is not yet focused on nutrition,
but given the traditionally poor Scottish diet this will need
to be addressed. Another example is the ENOUGH
program (which stands for essential nutrients for optimal
underpinning of growth and health) which uses multi-
system approaches (physiological using omics technolo-
gies, environmental, genetic, social conditions) to reach
two billion undernourished people [54]. Specifically in
developing countries, the use of mass media, including
social media, has been advocated to improve child-feeding
practices [55].
While scarce funding for research is a problem for the
entire global research community, the situation in many
low-income countries is dire. At best, a small fraction of
the gross domestic product is channeled to support
research, which results in heavy reliance on donors and
foreign agencies whose agendas do not necessarily reflect
the country’s needs, but who end-up dictating national
science agendas. African scientists educated abroad often
return to empty laboratories and large teaching loads. In
Table 2 The United Nations Millennium Development
Goals established by a target date of 2015
Goal number Millennium goal
Goal 1 Eradicate extreme hunger and poverty
Goal 2 Achieve universal primary education
Goal 3 Promote gender equality and empower women
Goal 4 Reduce child mortality
Goal 5 Improve maternal health
Goal 6 Combat HIV/AIDS, malaria and other diseases
Goal 7 Ensure environmental sustainability
Goal 8 Develop a global partnership for development
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African students to learn these methodologies and utilize
them at home to study areas of relevance to their country
and population. Thus, increased national funding of re-
search based on established priorities is clearly needed.
In Kenya, the National Commission for Science,
Technology and Innovation has managed to persuade
the Kenyan Government to allocate 2% of the gross
domestic product to research funding which is a positive
development, although it remains to be implemented. It
may be a good time for researchers of high standing to
support organizations like the National Commission or
equivalent in other countries to provide more support of
research. For example, in Canada, an advocacy orga-
nization, Research Canada, was formed to engage in influ-
encing the public policy process directly and indirectly
(http://www.rc-rc.ca/about-us). Researchers provide for-
ums to update Members of Parliament on new advances
in medical science. African scientists also could educate
the public on issues of research progress in various dis-
eases and conditions like malnutrition, and other factors
that affect health and longevity.
It is no secret that scientists and policy makers have
different goals, attitudes toward information, concept of
time and reporting structures [56]. The lack of under-
standing and respect and differing views on priorities
emphasizes the need to work together, have open dia-
logue and information sharing, and develop incentives to
advance evidence-based policy and practice. Given the
importance of the human and animal microbiomes and
their manipulation via probiotics, efforts to convey infor-
mation can only have a positive effect on the public
understanding these concepts.
Another constructive suggestion is to include in a
nation’s Food Guide a statement that fermented foods
should be taken regularly due to their many health bene-
fits. The rationale is supported by vast literature on the
health benefits of these foods through human history.
Increasing the impact of probiotics through food
In recent years, a practical approach has been under-
taken to transfer probiotic research and products to vul-
nerable adults and children in Tanzania, Kenya, Rwanda
and Uganda, including those who are HIV positive. The
concept utilizes locally sourced food and empowers
community members at the bottom-of-the-pyramid to
produce probiotic yogurt. This endeavor was motivated
by the eight United Nations Millennium Development
Goals, established in 2000 as a moral path towards
equality and health for all humankind (http://www.un.
org/millenniumgoals/bkgd.shtml; Table 2). Making pro-
biotic foods available to the poorest will contribute to all
but goal 2 (achieve universal primary education) of the
Millennium Development Goals [22,57-59]. An essentialand sustainable target is to empower local people to
establish social businesses, defined as ‘a non-loss, non-
dividend company designed to address a social objective
within the highly regulated marketplace of today’ [60], as
well as to make probiotics (both local and international)
more accessible to a larger population. The empower-
ment of women to create and run these social businesses
has so far proved successful [38,61].
However, the kitchen yogurt model requires support at
start-up by local medical research authorities, farmers
and foreign partners, and may be unsuitable to reach the
millions of people facing poverty, malnutrition, maternal
and infant morbidity and mortality and infectious dis-
eases. The delegates discussed the challenges in over-
coming this barrier.
One idea is to provide as many resource disadvantaged
people as possible with access to probiotic fermented
foods via affordable sachets containing shelf-stable bene-
ficial bacteria and micronutrients. The sachet contents
can be inoculated into milk to make yoghurt or added to
other foods and fermented, or simply sprinkled over
regular food. Figure 4 shows several production and
distribution channels for probiotic fermented foods
using existing infrastructures, or via home-use. Collabor-
ation across Kenya, Tanzania and Uganda could provide
an impetus, with efforts conjointly being made to expand
to Rwanda, Ethiopia and other neighboring countries
(Table 3). The focus for the 5,000 beneficiaries of the
current kitchens (10 in Tanzania, 3 in Kenya, 1 in Uganda)
is mothers, children, and HIV/AIDS patients. To attain a
goal of 500,000 recipients within 5 years, the products will
have to reach the broader population and take account of
local dietary habits. This might be via goat and camel milk
in Ethiopia, or through cereals in other regions.
The partnerships form critical components of the set-
up. Developed countries provide training for personnel
and laboratory resources to perform microbiome analysis,
genome sequencing, and probiotic research. In Africa,
facilities such as at ILRI provide a means for 16S sequen-
cing analysis. Collaborations can employ dissemination of
Figure 4 In order to provide nutritious, safe, local foods supplemented with probiotics and affordable to the bottom-of-the-pyramid,
the following model is proposed. Existing products, Fiti yogurt in Tanzania and Kenya, and Yoba-for-life in Uganda provide stepping stones,
and their distribution through community kitchens and mini-plants, and via dried sachets, with the aid of partnerships, is estimated to reach close
to one million people within 5 years.
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keeping, sanitation and food hygiene. This can also allow
African concepts to be pursued. For example, a novel pro-
biotic yogurt containing L. rhamnosus GR-1 and NN-20
created by Kenyans and Canadians is being tested in
Embu, Kenya, for its ability to reduce aflatoxin poisoning
from ingestion of corn and peanuts, through aflatoxin-
binding properties [62-64].
Sachets have already been developed by partners
Yoba-for-life (http://www.yoba4life.com), containing L.
rhamnosus Yoba and S. thermophilus. Their 1 g dried
contents, manufactured in The Netherlands, are added
to 1 liter pasteurized milk and incubated in existing
(small-scale) dairy production plants, then inoculated
into 50 liters to produce probiotic yogurt. This avoids
having to produce the probiotic Yoba at a separate site,
as currently is required for the L. rhamnosus GR-1 Fiti
yogurt produced by the Kenyan and Tanzanian kitchens.
The Uganda Industrial Research Institute trains the
personnel to set up and run their dairy plants, and one
currently provides yogurt to 1,000 people each day. Theplan is to reach 150,000 people within the next 2 years
through growth of dairy plants. The Yoba strain has
been extensively studied and shown to enhance immun-
ity and prevent and treat diarrhea which are issues com-
mon to the Ugandan consumers living under poverty
[39]. Depending on the production and sales point, the
yogurt costs approximately 1,400 UGX/L (approximately
US$0.56) to produce and is sold for 2,800 UGX/L
(approximately US$1.12) to the final consumer, allow-
ing a small profit for the employees at the production
and distribution site. This sales price is around 13
cents for an equivalent tub of probiotic yogurt sold in
Canada for over 43 cents.
This initiative, along with making sachets containing
L. rhamnosus GR-1 and NN-20, will not be without
challenges in education, product handling, control and
pricing, but the potential payoff will be significant. At a
minimum, re-introducing beneficial microbes into the
food chain and society will counter the negative fast
food, low nutrient products that have swept the market,
or staple foods like rice and maize that offer little in
Table 3 Examples of different approaches for three countries that collectively lead to increased availability of
probiotic food, including for the very poorest in society; the key engagement of partners is vital
Where Who What How For
Kenya • Teachnical University of Kenya,
Jomo Kenyatta University of
Agriculture and Technology
• Food Science and Technology,
and new product development
• Local yoghurt kitchens • People with HIV/AIDS
• Ministry of Agriculture, and Ministry
of Gender and Social Services
• Bottom of pyramid business
development
• Train-the-trainer workshops • People exposed to
aflatoxins and other
population
• Local production of Fiti yogurt • Lactobacillus rhamnosus GR-1 anti-
infective and immunomodulatory
effects
• General population
• Distribution networks for sachets • Weissella spp. NN-20 detoxication
effects
Tanzania • Western Heads East internship
program
• Local production of Fiti yogurt • Local yoghurt kitchens • People with HIV/AIDS
• African Probiotic Yogurt Network • Supplemented with Moringa and
potentially other micronutrient-rich
foods
• Train-the-trainer workshops • General population
• National Institute for Medical
Research support
• Distribution networks for sachets • Addition of Moringa
Uganda • Yoba for Life Foundation • Local production of probiotic Yoba • Local production plants • General population
• Uganda Industrial Research
Institute
• Food Science and Technology
product development
• Using existing infrastructures
• Makarere University • Bottom of pyramid social business
development
• Train-the-trainer workshops
• Heifer International • Incubator programs • Lactobacillus rhamnosus Yoba
for gut health
• Local dairy producers • Distribution networks for sachets
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aim will be to retain the social business, bottom-of-the-
pyramid model [48]. While competitors exist now and
will do so later, at least in the yogurt market, their prod-
ucts are expensive and without probiotic added value,
and they will always have a market, especially as incomes
increase with developments occurring in the region. But,
for as long as millions of children and adults live in
poverty and an environment where infectious diseases
and other ailments affect them, the need for affordable,
nutritional products will exist.
Summary
The following recommendations emerged from this
productive workshop.
1. Africa is on the verge of novel and exciting research
on the microbiome and probiotics. We recommend
that partnerships be created or expanded that enable
the science, help train personnel, and translate
evidence-based solutions in a continual circle of
activity which integrates microbiome and probiotic
research with products that benefit societies, no
matter their cultural diversity.2. Studies are critically needed to understand the
microbiome of animals, soil, plants, insects and
humans in the African continent, so as to create a
platform for innovative advances in how health is
restored and maintained.
3. Efforts are urgently required to take probiotic
concepts in affordable food formulations and
facilitate access to those who need them most. This
will help reduce the risk of morbidity and mortality
especially for women and newborns. Both the
production and distribution of traditional local and
international probiotics should be investigated.
Probiotics are not a substitute for vaccines, certain
drugs, hygiene practices and nutritious food, but
until these options reach the most needy, probiotics
can help save many lives and turn the societal
culture back to some of the traditional foods that
benefited past generations.
4. Programs are needed in primary/secondary schools
and communities to embrace the healthful
consumption of traditional foods and to resist
dietary myths or new fads of fast, poor nutritional
foods. Education at the college and university levels
is needed to introduce the new field of microbiome
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of ‘omics’ fields. Likewise, knowledge must be
conveyed to the politicians who are the gatekeepers
of resources. For that, we suggest the support for
Research Councils composed of respected and
innovative African researchers.
5. Lastly, African governments should invest in
research on the microbiome and probiotics with
tangible funding that provides their scientists,
physicians and other researchers with the facilities
and operating grants to train students, and develop
community-based solutions to community-based
problems. By doing so, the return on investment will
far outweigh the output, with savings in healthcare
and development of new businesses and products
for exportation. It is no longer an option to rely on
foreign philanthropy, when Africans have the
knowledge, are keen to acquire the training and
already show the determination to lead the field not
follow it. None of the Millennium Development
Goals can be reached without such an investment
and without the encouragement of two-way
partnerships.
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